Intimation of Revised Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Date: 3rd November, 2026 To, To, National Stock Exchange of India Limited (“NSE”), BSE Limited (“BSE”), The Listing Department Corporate Relationship Department, Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, Bandra-Kurla Complex Bandra P.J. Towers, Dalal Street, (East), Mumbai – 400 051. Mumbai – 400 001. NSE Symbol: STALLION BSE Scrip Code: 544342 ISIN: INE0RYC01010 ISIN: INE0RYC01010 Dear Sir/Madam, Sub: Intimation of Revised Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, (“SEBI Listing Regulations”), read with Part A of Schedule III to the SEBI Listing Regulations, we wish to inform you that the meeting of the management of Stallion India Fluorochemicals Limited (“the Company”) with Analyst/Investors, earlier scheduled on Tuesday, 3rd November, 2026 and intimated vide our letter dated 30th October, 2026, has been rescheduled to Friday, 6th November, 2026. The revised details are given below: Sr. No. Name Mode Time (IST) 1 Mr. Ajay Upadhyaya Virtual meeting 3:30 PM Note: The above schedule is subject to change due to exigencies on the part of the Company or the concerned analysts/investors. Any changes in the schedule will be intimated to the Stock Exchanges, wherever required. No unpublished price sensitive information (UPSI) will be discussed. We request you to kindly take the same on records. Yours faithfully, For Stallion India Fluorochemicals Limited Govind Rao Company Secretary & Compliance Officer Membership No.: A47094